[The effect of pyrimidine derivatives on experimental stomach ulcers in rats]. 1998

A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and Z F Ismagilova, and F P Savitskiĭ, and Iu G Tropynina, and V A Davydova, and V P Krivonogov
Institute of Organic Chemistry, Ufa Research Center, Russian Academy of Sciences, Russia.

Experiments on albino rats showed that pyrimidine derivatives reduce hemorrhagic damage of the gastric mucosa caused by indomethacin, acetylsalicylic acid, and ortophen. The derivatives of pyrimidine prevent the decrease in total acid phosphatase activity, increase alkaline phosphatase, and reduce the activity of lactate dehydrogenase.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D010432 Pentoxyl 5-Hydroxymethyl-6-methyl- 2,4-(1H,3H)-pyrimidinedione. Uracil derivative used in combination with toxic antibiotics to lessen their toxicity; also to stimulate leukopoiesis and immunity. Synonyms: pentoksil; hydroxymethylmethyluracil.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D004008 Diclofenac A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. Diclophenac,Dichlofenal,Diclofenac Potassium,Diclofenac Sodium,Diclonate P,Dicrofenac,Feloran,GP-45,840,Novapirina,Orthofen,Orthophen,Ortofen,SR-38,Sodium Diclofenac,Voltaren,Voltarol,Diclofenac, Sodium,GP 45,840,GP45,840,SR 38,SR38
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D000897 Anti-Ulcer Agents Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. Anti-Ulcer Drugs,Agents, Anti-Ulcer,Anti Ulcer Agents,Anti Ulcer Drugs,Drugs, Anti-Ulcer
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic

Related Publications

A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and Z F Ismagilova, and F P Savitskiĭ, and Iu G Tropynina, and V A Davydova, and V P Krivonogov
September 1964, Biulleten' eksperimental'noi biologii i meditsiny,
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and Z F Ismagilova, and F P Savitskiĭ, and Iu G Tropynina, and V A Davydova, and V P Krivonogov
January 1968, Acta physiologica Polonica,
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and Z F Ismagilova, and F P Savitskiĭ, and Iu G Tropynina, and V A Davydova, and V P Krivonogov
October 1974, Vrachebnoe delo,
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and Z F Ismagilova, and F P Savitskiĭ, and Iu G Tropynina, and V A Davydova, and V P Krivonogov
January 1983, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and Z F Ismagilova, and F P Savitskiĭ, and Iu G Tropynina, and V A Davydova, and V P Krivonogov
January 1975, Archivum immunologiae et therapiae experimentalis,
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and Z F Ismagilova, and F P Savitskiĭ, and Iu G Tropynina, and V A Davydova, and V P Krivonogov
January 1978, Farmakologiia i toksikologiia,
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and Z F Ismagilova, and F P Savitskiĭ, and Iu G Tropynina, and V A Davydova, and V P Krivonogov
January 1963, Voprosy onkologii,
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and Z F Ismagilova, and F P Savitskiĭ, and Iu G Tropynina, and V A Davydova, and V P Krivonogov
September 1965, Biulleten' eksperimental'noi biologii i meditsiny,
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and Z F Ismagilova, and F P Savitskiĭ, and Iu G Tropynina, and V A Davydova, and V P Krivonogov
January 2022, Evidence-based complementary and alternative medicine : eCAM,
A F Ismagilova, and F S Zarudiĭ, and D N Lazareva, and Z F Ismagilova, and F P Savitskiĭ, and Iu G Tropynina, and V A Davydova, and V P Krivonogov
January 1986, Zeitschrift fur mikroskopisch-anatomische Forschung,
Copied contents to your clipboard!